期刊文献+

综合重症监护病房医院感染干预的临床研究 被引量:14

Clinical Study of Interventions of Nosocomial Infection in Comprehensive Intensive Care Unit
原文传递
导出
摘要 目的加强综合重症监护病房的医院感染管理,提高医疗质量。方法医院感染管理部门建立医院感染管理制度和规范并予督查,实施目标性监测,干预医院感染的发生;综合重症监护病房成立医院感染管理小组,落实医院感染防控措施。结果通过对医院感染的干预和预防,减少综合重症监护病房的医院感染的发生。结论多途径加强医院感染管理,严格监控质量,是提高医疗质量、确保医疗安全的可靠保证。 OBJECTIVE To strengthen management of nosocomial infections in comprehensive intensive care unit so as to enhance medical treatment quality. METHODS Nosocomial infection administration department constituted the management institutions and standards of nosocomial infections with supervising, implementing targets monitoring. Comprehensive intensive care unit instituted several groups of nosocornial infection management and fulfiled the precautions and control, measures. RESULTS By means of interventions and prophylaxes, the occurrence of nosocomial infection in comprehensive intensive care unit decreased. CONCLUSIONS It ensures for medical treatment quality and safe by strengthening the management of nosocomial infections.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2009年第21期2916-2918,共3页 Chinese Journal of Nosocomiology
关键词 重症监护病房 医院感染 干预 Intensive care unit Nosocomial infection Intervention
  • 相关文献

参考文献4

二级参考文献20

  • 1[1]Lam JS, Gupta M. Tips and tricks for the management of retained ureteral stents [J]. J Endourol, 2002, 16(10):733- 741.
  • 2[2]Nunes AC, Romaozinho JM, Pontes JM, et al. Risk factors for stricture development after caustic ingestion [ J ]. Hepatogastroenterology, 2002,49(48): 1563 - 1566.
  • 3[3]Karzai W, Oberhoffer M, Meier- Hellmann A, et al. Procalcitonin - a new indicator of the systemic response to severe infections [J]. Infection,1997, 25(6) :329 - 334.
  • 4[4]Guven H, Altintop L, Baydin A, et al. Diagnostic value of procalcitonin levels as early indicator of sepsis[J]. Am J Emerg Med, 2002, 20(3):202 - 206.
  • 5[5]American college of chest physicians/society of critical care medicine consensus conference. Definitions for sepsis and mutiple organ failure and guidelines for the use of innovative therapies in sepsis[J]. Crit Care Med, 1992, 20(6):864-874.
  • 6[7]Wanner GA, Keel M, Steckholzer U, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure,and mortality in injured patients [J]. Crit Care Med, 2000, 28(4) :950- 957.
  • 7[8]Redl H, Schlag G, Togel E, et al. Procalcitonin release patterns in a baboon model of trauma and sepsis: relationship to cytokines and neopterin[J].Crit CareMed,2000,28(11):3659-3663.
  • 8[10]Muller Werdan U. Septic shock and systemic inflammatory response syndrome diagnosis [ J]. Dtsch Med Wochenschr, 2003, 128 (45):2368 - 2371.
  • 9[11]Leclerc F, Cremer R, Noizet O. Procalcitonin as a diagnostic and prognostic biomarker of sepsis in critically ill children [J]. Pediatr Crit Care Med, 2003, 4(2):264-266.
  • 10[12]Neely AN, Fowler LA, Kagan RJ, et al. Procalcitonin in pediatric bm patients: an early indicator of sepsis [J]? J Bum Care Rehabil,2004, 25(1):76-80.

共引文献116

同被引文献64

引证文献14

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部